BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25885587)

  • 1. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
    Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y
    BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in immunoglobulin A nephropathy
.
    Kim JS; Jeong KH
    Clin Nephrol; 2020 Feb; 93(2):99-105. PubMed ID: 31829928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
    Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of urinary full-length megalin in patients with IgA nephropathy.
    Seki T; Asanuma K; Asao R; Nonaka K; Sasaki Y; Oliva Trejo JA; Kurosawa H; Hirayama Y; Horikoshi S; Tomino Y; Saito A
    PLoS One; 2014; 9(12):e114400. PubMed ID: 25502002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    Tezuka Y; Eguchi-Ishimae M; Ozaki E; Ito T; Ishii E; Eguchi M
    PLoS One; 2021; 16(10):e0258090. PubMed ID: 34597335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy.
    Zhao Y; Liu L; Huang J; Shi S; Lv J; Liu G; Zhao M; Zhang H
    PLoS One; 2015; 10(7):e0132869. PubMed ID: 26167688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
    Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
    J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14.
    Guo Y; Liao Y
    Int Immunopharmacol; 2017 Nov; 52():150-155. PubMed ID: 28910745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy.
    Kodama F; Asanuma K; Takagi M; Hidaka T; Asanuma E; Fukuda H; Seki T; Takeda Y; Hosoe-Nagai Y; Asao R; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2013 Jul; 28(7):1762-72. PubMed ID: 23143340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
    Schwartz N; Rubinstein T; Burkly LC; Collins CE; Blanco I; Su L; Hojaili B; Mackay M; Aranow C; Stohl W; Rovin BH; Michaelson JS; Putterman C
    Arthritis Res Ther; 2009; 11(5):R143. PubMed ID: 19785730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.
    Lai KN; Leung JC; Chan LY; Saleem MA; Mathieson PW; Tam KY; Xiao J; Lai FM; Tang SC
    Nephrol Dial Transplant; 2009 Jan; 24(1):62-72. PubMed ID: 18685143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
    Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
    Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK, a multifunctional cytokine in kidney injury.
    Sanz AB; Sanchez-Niño MD; Ortiz A
    Kidney Int; 2011 Oct; 80(7):708-18. PubMed ID: 21697814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological differences in new-onset IgA nephropathy between children and adults.
    Ikezumi Y; Suzuki T; Imai N; Ueno M; Narita I; Kawachi H; Shimizu F; Nikolic-Paterson DJ; Uchiyama M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary TWEAK and the activity of lupus nephritis.
    Schwartz N; Su L; Burkly LC; Mackay M; Aranow C; Kollaros M; Michaelson JS; Rovin B; Putterman C
    J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
    Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
    J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 are expressed in urticarial vasculitis.
    Li M; Chen T; Guo Z; Li J; Cao N
    J Dermatol; 2013 Nov; 40(11):891-5. PubMed ID: 23968277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
    Peng QL; Shu XM; Tian XL; Lu X; Wang GC
    Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.